Shares of Tvardi Therapeutics TVRD nosedived 83.9% on Monday after the company provided a disappointing update following an ...

The HERCULES trial shows pembrolizumab plus chemotherapy produces a 39.4% response rate in advanced penile cancer, offering ...

Introduction The Sport Mental Health Assessment Tool-1 (SMHAT-1) was developed to screen elite athletes for mental health concerns. Previous work demonstrated high false negative rates (FNRs) for the ...

Shares of Ovid Therapeutics OVID rallied 39.2% primarily driven by the encouraging top-line data readout from an early-stage ...

With only $41 million in cash, Tvardi Therapeutics may need to raise additional funds within a one-year period. Click here to ...

Tvardi Therapeutics’ stock has crashed more than 80% after the company revealed that its idiopathic pulmonary fibrosis (IPF) ...

SUTD researchers test a privacy-preserving approach that blends federated learning with cloud coordination for smart grids in ...

Pulsar Helium (AIM: PLSR; TSXV: PLSR; WKNA3EP2C ) has mobilized a drill rig and associated equipment to its flagship Topaz ...

A new study explores “heartbeat consumption,” a fitness metric that counts daily heartbeats. Could smartwatches soon track ...

Liz Simmons is an education staff writer at Forbes Advisor. She has written about higher education and career development for various online publications since 2016. She earned a master’s degree in ...